drugset / Trial / NCT00374543
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study proposes to examine the potential safety and efficacy of ziprasidone for patients with anxiety and bipolar disorder on anxiety outcomes, bipolar symptoms, and on measures of quality of life and resilience.
Timeline
- Start
- 2006-02
- Primary completion
- 2007-10
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 40 mg | — |
| Subject | Ziprasidone | Small molecule | 160 mg | — |